Thanks to the effort of all the team that forms Bioithas, we are proud to have a wide and innovative Pipeline.
All Bioithas projects have different phases, beginning with a preclinical trials through to finally obtaining the license / validation phase of the product, both nationally and in the countries required, for subsequent commercialization.
If your Company is interested in one of these products, do not hesitate to contact with Bionou Research, the final owner/co-owner of these final products
|OTHER SKIN DISEASE|
(contact, previos CDA necessary)
|FATTY LIVER||Probiotic||Metabolic Syndrome|
|VIRAL INFECTIONS||Probiotic||Infectious Diseases|
|ANTIBIOTIC SIDE EFFECTS (Diarrhea@Antibiotic resistance)||Probiotic-Antibiotic||Infectious Diseases|
|MULTIPLE SCLEROSIS||Diagnostic Biomarker||Neurology|
|ORAL CAVITY /PHARYNGEAL CANCER||Diagnostic Biomarker||Oncology|